METTL3 and cancer: Consistent with our results, it has been demonstrated that METTL3 is upregulated in cancer tissues compared with the adjacent normal tissues in human breast cancer and gastric cancer, and it also can be used as a candidate target for individualized treatments against these malignancies [13, 25].